919 Ribosomal protein L36
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 38 | 18.4 | 2.07× | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 1 | 10.4 | 0.10× | q = 4.6e-4 | |
| Homogeneous non-metal compounds | 0 | 8.1 | 0 | q = 5.7e-4 | |
| Organic acids and derivatives | 0 | 5.8 | 0 | q = 6.0e-3 | |
| Organic oxygen compounds | 0 | 7.5 | 0 | q = 9.6e-4 | |
| Organoheterocyclic compounds | 0 | 5.8 | 0 | q = 6.1e-3 | |
| Organic nitrogen compounds | 1 | 1.2 | 0.84× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01917 | PUT | Putrescine | 1 |
| DB03403 | C | Cytidine-5'-Monophosphate | 1 |
| DB03685 | U | Uridine monophosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 829 |
| MGmetal | MAGNESIUM ION | 349 |
| Kmetal | POTASSIUM ION | 5 |
| MNmetal | MANGANESE (II) ION | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |
| PUT | 1,4-DIAMINOBUTANE | 1 |